Compare LXRX & REPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LXRX | REPX |
|---|---|---|
| Founded | 1995 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 703.3M | 776.6M |
| IPO Year | 2000 | 2003 |
| Metric | LXRX | REPX |
|---|---|---|
| Price | $2.38 | $32.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $4.15 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 4.1M | 256.9K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 4.41% |
| EPS Growth | 77.78 | ★ 78.17 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $49,803,000.00 | $3,038,000.00 |
| Revenue This Year | N/A | $33.41 |
| Revenue Next Year | N/A | $13.46 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 60.24 | N/A |
| 52 Week Low | $0.87 | $24.08 |
| 52 Week High | $2.68 | $41.53 |
| Indicator | LXRX | REPX |
|---|---|---|
| Relative Strength Index (RSI) | 60.77 | 41.43 |
| Support Level | $1.52 | $32.30 |
| Resistance Level | $2.53 | $36.85 |
| Average True Range (ATR) | 0.15 | 1.17 |
| MACD | 0.05 | -0.07 |
| Stochastic Oscillator | 63.69 | 9.95 |
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Riley Exploration Permian Inc is engaged in the business of exploration for and production of oil and natural gas. The company operations include: The Permian Basin is an oil and natural gas producing area located in West Texas.